Skip to main content

Animations

MJFF Publications

5221 - 5230 of 6570 Results
Title
Year
  • Year
  • 2023
  • 2021
  • 2022
  • 2023
  • 2024
  • 2023
  • 2020
  • 2024
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Genetic Testing in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29500
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Systematic characterization of human gut microbiome-secreted molecules by integrated multi-omics
    Journal Name: ISME Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s43705-021-00078-0
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Decreased Water Mobility Contributes To Increased α‐Synuclein Aggregation**
    Journal Name: Angewandte Chemie
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/ange.202212063
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Brain‐Targeted Liposomes Loaded with Monoclonal Antibodies Reduce Alpha‐Synuclein Aggregation and Improve Behavioral Symptoms in Parkinson's Disease
    Journal Name: Advanced Materials
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/adma.202304654
    Citation Count: 83
  • Summary Details
    OPEN
    Title: Combinatorial selective ER-phagy remodels the ER during neurogenesis
    Journal Name: Nature Cell Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41556-024-01356-4
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer’s disease, restores synapse integrity and memory in a disease mouse model
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.89453
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Epigenome-wide association study of Alzheimer’s disease replicates 22 differentially methylated positions and 30 differentially methylated regions
    Journal Name: Clinical Epigenetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13148-020-00944-z
    Citation Count: 80
  • Summary Details
    OPEN
    Title: SRF transcriptionally regulates the oligodendrocyte cytoskeleton during CNS myelination
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2307250121
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Integrative genomics approach identifies conserved transcriptomic networks in Alzheimer’s disease
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/hmg/ddaa182
    Citation Count: 83
  • Summary Details
    OPEN
    Title: The Alzheimer's disease‐associated C99 fragment of APP regulates cellular cholesterol trafficking
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/embj.2019103791
    Citation Count: 118
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.